User profiles for Elie Gertner
Elie GertnerUniversity of Minnesota Medical School Verified email at umn.edu Cited by 2211 |
[PDF][PDF] Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome
Objective The objective of this study was to report the benefit of a therapeutic approach
consisting of intravenous ( IV ) continuous anakinra (recombinant human interleukin‐1 receptor …
consisting of intravenous ( IV ) continuous anakinra (recombinant human interleukin‐1 receptor …
Guidelines for treatment of Susac syndrome–An update
…, N Asdaghi, S Srivastava, E Gertner - … journal of stroke, 2020 - journals.sagepub.com
Susac syndrome is an immune-mediated, pauci-inflammatory, ischemia-producing, occlusive
microvascular endotheliopathy/basement membranopathy that affects the brain, retina, …
microvascular endotheliopathy/basement membranopathy that affects the brain, retina, …
Working memory capacity is decreased in sleep-deprived internal medicine residents
A Gohar, A Adams, E Gertner… - Journal of Clinical …, 2009 - jcsm.aasm.org
Background: Concerns about medical errors due to sleep deprivation during residency training
led the Accreditation Council for Graduate Medical Education to mandate reductions in …
led the Accreditation Council for Graduate Medical Education to mandate reductions in …
Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels
BACKGROUND: Arthrocentesis and joint injections are commonly performed for both
diagnostic and therapeutic indications. Because of safety concerns, there is often reluctance to …
diagnostic and therapeutic indications. Because of safety concerns, there is often reluctance to …
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator …
BACKGROUND: Current guidelines recommend stopping oral anticoagulation and starting
bridging anticoagulation with intravenous heparin or subcutaneous enoxaparin when …
bridging anticoagulation with intravenous heparin or subcutaneous enoxaparin when …
Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs
E Gertner, PS Marshall, D Filandrinos… - … : Official Journal of …, 1995 - Wiley Online Library
Objective. Many patients with chronic disease use alternative therapies. Our objective was
to investigate complications resulting from the use of Chinese herbal medications containing …
to investigate complications resulting from the use of Chinese herbal medications containing …
[HTML][HTML] Off‐label therapies for COVID‐19—Are we all in this together?
JD Alpern, E Gertner - Clinical pharmacology and therapeutics, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) continues to spread rapidly
outside of mainland China. As of April 6, 2020, there are over 300,000 cases and 10,000 …
outside of mainland China. As of April 6, 2020, there are over 300,000 cases and 10,000 …
Anakinra for the treatment of acute severe gout in critically ill patients
JT Thueringer, NK Doll, E Gertner - Seminars in Arthritis and Rheumatism, 2015 - Elsevier
Objectives To report on the efficacy and safety of anakinra for treatment of acute gouty
arthritis in medically complex, critically ill patients. Methods Retrospective chart review of 13 …
arthritis in medically complex, critically ill patients. Methods Retrospective chart review of 13 …
[HTML][HTML] Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report
Background Novel immune checkpoint inhibitors have been often utilized for different types
of malignancies as salvage therapy with varying success. One obstacle to immune …
of malignancies as salvage therapy with varying success. One obstacle to immune …
Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment.
E Gertner - The Journal of Rheumatology, 1999 - europepmc.org
Objective To describe clinical manifestations, laboratory findings, and treatment of patients
with the antiphospholipid syndrome (APS) who develop diffuse alveolar hemorrhage. …
with the antiphospholipid syndrome (APS) who develop diffuse alveolar hemorrhage. …